Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Trends That Matter for Social Engagement

Posted by Matt Breese on Sep 19, 2017

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is social media engagement.

Pharma companies are beginning to shift their social media strategies to focus less on broadcasting and more on listening. When done well, a consistent social media presence will provide many opportunities for your company to facilitate valuable conversations. 

Read More

Topics: Industry Trends, Branding & Marketing

Trends That Matter for Hereditary Angioedema

Posted by Matt Breese on Sep 14, 2017

In our weekly Trends that Matter series, we provide engaging infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is advancements in Hereditary Angioedema (HAE) treatment.

The HAE therapeutic landscape is expanding rapidly. However, factors such as access, side effects, and cost still limit some patients from receiving treatment. All products are considered specialty drugs, and there is only one option for a self-administered product.

Read More

Topics: Specialty

Perspectives on 2017 Approvals

Posted by Matt Breese on Sep 12, 2017

When the FDA’s Center for Drug Evaluation and Research approves new drugs, this expands patient treatment options and often makes healthcare advancements. So far this year, the FDA has approved 31 new drugs. New drug approvals may come in the form of entirely new products, or they may be for drugs similar to previously approved products. 

While the process of getting a new pharmaceutical drug approved and onto the market is lengthy and expensive for manufacturers, this helps ensure that drugs are safe and effective for patients.

Read More

Topics: Industry Trends

MMIT Reality Check on Narcotic Pain (Sep 2017)

Posted by Matt Breese on Sep 11, 2017

According to our recent payer coverage analysis for narcotic pain treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

Trends That Matter for Medical AI

Posted by Matt Breese on Sep 7, 2017

In our weekly Trends that Matter series, we provide engaging infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is what consumers think about the potential applications of artificial intelligence (AI) in the healthcare field.

Many health IT companies are already beginning to experiment with AI in the hopes of solving complex medical challenges. For example, the company Triggr Health uses machine learning to help individuals recover from opioid, alcohol, and other substance dependencies.

Read More

Topics: Industry Trends

Perspectives on Recognizing Signs of Change

Posted by Matt Breese on Sep 5, 2017

How can pharma leaders improve their approach to market access analysis, planning and execution? Pharma teams must keep a close eye on the market for competitive threats and economic shifts. Identifying friction in the current process of communicating market access, policy and restriction information often creates the initial momentum for a change.

However, when many brand teams look internally or to their existing partners for a solution, they find that there is a disconnect between current capabilities and the actual business need.

Read More

Topics: Market Access

Trends That Matter for Heart Disease Treatment

Posted by Matt Breese on Aug 31, 2017

In our weekly Trends that Matter series, we provide engaging infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is potential developments in the area of heart disease treatment.

Cardiovascular disease has typically been treated by methods that focus on lowering cholesterol or reducing blood pressure. However, a recent study has indicated that reducing inflammation levels may help prevent heart attack patients from experiencing a stroke or a second heart attack.

Read More

Topics: Specialty

MMIT Reality Check on Immunology: Rheumatoid Arthritis (Aug 2017)

Posted by Matt Breese on Aug 31, 2017

According to our recent payer coverage analysis for rheumatoid arthritis treatments, combined with news from key healthcare influencers, market access is shifting in this immunology drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

Perspectives on Field Force Excellence

Posted by Matt Breese on Aug 29, 2017

How can pharma sales teams overcome the challenges that arise with limited HCP facetime? One method is by focusing on understanding clinician preferences at the individual level. By aligning marketing and sales efforts, field teams can reach out to clinicians with a unified and clear message.

The key to building an excellent field force is through training on both processes and tools. According to Jaideep Bajaj, Chairman at ZS Associates, sales teams need to have an "orchestrator rep" who oversees all outreach to clinicians. The orchestrator rep is responsible for tailoring sales and marketing efforts to a clinician's unique preferences.

Read More

Topics: Branding & Marketing

Trends That Matter for Psoriasis Treatment

Posted by Matt Breese on Aug 24, 2017

In our weekly Trends that Matter series, we provide engaging infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. In honor of Psoriasis Awareness Month, this week's featured topic is the state of psoriasis treatment.

In today's landscape, there are many safe and effective treatment options available for individuals with psoriasis and psoriatic arthritis. Disease-modifying antirheumatic drugs (DMARDs) can relieve severe symptoms and attempt to slow progression with psoriatic arthritis. 

Read More

Topics: Specialty